Cardinal Health, Inc.

🇺🇸New York Stock Exchange
Back to all articles
Cardinal Health, Inc. stock analysis CAH overview
Slightly Bullish +25

We're buying more shares of a company immune from the Iran war uncertainty

📈 Jim Cramer's Charitable Trust is purchasing additional shares of Cardinal Health (CAH) at approximately $214 each following Wednesday's trade.

💼 The charitable trust will increase its holdings to 450 shares, raising the stock's portfolio weighting from 2.27% to 2.55%.

🛡️ CAH is favored because it generates nearly 100% of its revenue within the United States, making it immune to geopolitical tensions related to the Iran conflict.

⛽ Recent oil price spikes and Middle East uncertainty caused energy stocks to sell off, driving a S&P 500 decline of more than 0.5%.

📉 The health care sector has been the second-worst-performing sector this month due to concerns over geopolitical impacts on economic growth.

🛑 Cardinal Health's stock sentiment has soured following announcements that two major competitors, McKesson and Cencora, announced their CFOs' retirements.

🤲 Management reassured analysts at Leerink that recent commodity spikes will be immaterial to the company's fiscal year 2026 earnings.

📉 The S&P Short Range Oscillator momentum indicator remains technically oversold at -5.18%, suggesting potential market rebound opportunities.

🕒 Trade executions by Jim Cramer follow specific timing rules, such as waiting 45 minutes after sending trade alerts before making moves in the charitable trust.

🔄 Previous investments included buying several times since the war's breakout despite early mistakes starting the position slightly too soon.

Bullish Signals
  • Cardinal Health generates nearly 100% of its revenue within the United States, making it immune to geopolitical tensions and energy price volatility caused by Middle East conflict.
  • Management told analysts at Leerink that recent commodity spikes will be immaterial to fiscal year 2026 earnings despite rising oil prices.
  • The company offers insulation from war-related uncertainty, prompting the Charitable Trust to increase its position weighting from 2.27% to 2.55% following Wednesday's trade.
  • Cencora reaffirmed its full-year earnings per share (EPS) adjusted guidance range on Tuesday, easing concerns about an impending shortfall after CEO and CFO announcements.
Risk Factors
  • Healthcare is the second-worst-performing sector in the market this month, raising concerns about defensive groups failing to perform well when geopolitical tensions impact economic growth.
  • Sentiment in the drug distributor group has soured after not one, but two finance chiefs announced their retirement (McKesson's CFO on March 5 and Cencora's CFO on March 17), indicating potential leadership instability.
  • The investment strategy involves building up a position despite acknowledging the mistake of 'starting a little too early,' suggesting the current entry point may be suboptimal.
  • Jim Cramer's Charitable Trust execution rules create delays in trading—waiting 45 minutes after trade alerts and 72 hours if discussed on CNBC—which could result in missing immediate market opportunities or reacting to news already priced in.
  • Cardinal Health's insulation from geopolitical tensions relies heavily on generating nearly 100% of its revenue within the United States, which may limit diversification benefits if domestic conditions deteriorate.
Full Analysis
Jim Cramer's Charitable Trust is increasing its stake in Cardinal Health (CAH) by purchasing an additional 50 shares at approximately $214 per following Wednesday's trading activity. This transaction brings the charitable trust's total holdings of CAH to 450 shares, raising the company's weighting in the portfolio from 2.27% to 2.55%. The investment decision is driven by the stock's perceived immunity to geopolitical risks stemming from the ongoing conflict in the Middle East, specifically citing that Cardinal Health generates nearly 100% of its revenue within the United States. The broader market context features significant uncertainty regarding the potential escalation of the Iran war, with energy prices rising—Brent international crude nearing a high since July 2022 and West Texas Intermediate hovering around $100 per barrel—which has contributed to an S&P 500 decline of more than 0.5%. Cramer's Charitable Trust views the market as technically oversold, with the S&P Short Range Oscillator momentum indicator at minus-5.18%, well below the minus-4% threshold, suggesting a potential rebound on positive news. While the healthcare sector has underperformed this month despite defensive expectations, management from Cardinal Health recently reassured analysts at Leerink that commodity spikes will be immaterial to its fiscal year 2026 earnings. The investment rationale acknowledges that sentiment in the drug distributor group has soured due to consecutive CFO retirements at McKesson on March 5 and Cencora on March 17, though these events are considered coincidental rather than a red flag. This was further supported by Cencora reaffirming its full-year earnings per share adjusted guidance range. Although Cardinal Health started as an earlier purchase that the trust acknowledges was made slightly early, the team is continuing to add to the position on weakness because of its insulation from overseas geopolitical tensions. Jim Cramer notes specific trading protocols for subscribers to his CNBC Investing Club, including waiting 45 minutes after a trade alert or 72 hours if the stock has been discussed on CNBC TV before executing trades in the charitable trust portfolio.